Disease Info Card

Beta-galactosidase Deficiency

Information about Beta-galactosidase Deficiency: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Beta-galactosidase Deficiency

Most recent studies have shown that Beta-galactosidase Deficiency shares some biological mechanisms with ataxia, dwarfism, galactosialidosis, gangliosidoses, gangliosidosis-generalized-gm1-type-1-(disorder), gangliosidosis-gm1, inborn-errors-of-metabolism, lactose-intolerance, lysosomal-storage-diseases, mucolipidoses, mucopolysaccharidoses, mucopolysaccharidosis-iv, mucopolysaccharidosis-type-ivb, myoclonus, nervousness, neuraminidase-1-deficiency, pfaundler-hurler-syndrome, storage-disease, type-i-mucolipidosis, type-ii-mucolipidosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Beta-galactosidase Deficiency, and have been seen in publications frequently: Central Nervous System Myelination, Elastic Fiber Assembly, Excretion, Localization, Methylation, Muscle Atrophy, Myelination, Ossification, Pathogenesis, Pigmentation, Proteolysis, Secondary Growth, Translation, Transport

Quite a number of genes have been found to play important roles in Beta-galactosidase Deficiency, such as ARSH, CAT, CHRM1, CRAT, CTSA, CTSB, DYM, EBP, ELN, GALC, GALNS, GLB1, GLYAT, GUSB, MTCH1, NEU1, PPP1R3A, PSAP, PSMD4, SH3D19. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.